oa South African Medical Journal - A critical appraisal of anticoagulant therapy



In summary, we must conclude that as from 1967, the total world evidence suggests that in the absence of compelling contraindications and with the availability of satisfactory laboratory and clinical facilities, patients suffering from acute myocardial infarction should receive adequate anticoagulant therapy during the first month, and that the risk of re-infarction and death is reduced if this is continued for 1 - 2 years after the first month.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error